These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 608570)

  • 61. [Dissolution of biliary calculi with CDCA and UDCA].
    Sugata F
    Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
    [No Abstract]   [Full Text] [Related]  

  • 62. Gallstone recurrence after successful dissolution therapy.
    Tudyka J; Wechsler JG; Kratzer W; Maier C; Mason R; Kuhn K; Adler G
    Dig Dis Sci; 1996 Feb; 41(2):235-41. PubMed ID: 8601364
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The present status of agents for dissolving gallstones.
    Tangedahl T
    Am J Gastroenterol; 1985 Jan; 80(1):64-6. PubMed ID: 3881015
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K
    Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatoprotective bile acid 'ursodeoxycholic acid (UDCA)' Property and difference as bile acids.
    Ishizaki K; Imada T; Tsurufuji M
    Hepatol Res; 2005 Oct; 33(2):174-7. PubMed ID: 16214392
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ursodeoxycholic acid treatment of gallstones.
    Thistle JL
    Semin Liver Dis; 1983 May; 3(2):146-56. PubMed ID: 6346500
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
    Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy.
    Tazuma S; Kajiyama G; Mizuno T; Yamashita G; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Ochi H; Matsumoto T; Abe A; Adachi K; Omata F; Ueno F; Sugata F; Ohguri S; Shibata H; Kokubu S
    J Clin Gastroenterol; 1998 Jun; 26(4):287-91. PubMed ID: 9649013
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Lancet; 1978 May; 1(8074):1111-4. PubMed ID: 77412
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Tauro-ursodeoxycholic acid vs. ursodeoxycholic acid in the dissolution of biliary calculi. Results of a single blind study].
    Gallo V; De Micheli AG; Chiandussi L
    Clin Ter; 1993 Nov; 143(5):421-8. PubMed ID: 8275659
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
    van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
    Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
    Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
    Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
    Leuschner U; Schneider M; Korte L
    Z Gastroenterol; 1979 Apr; 17(4):244-55. PubMed ID: 433375
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gut Microbial Profile Changes in Patients with Gallbladder Stones after UDCA/CDCA Treatment.
    Lee J; Lee S; Kim H; Bae J; Park JS
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979756
    [No Abstract]   [Full Text] [Related]  

  • 79. Treatment of cholesterol gallstones with litholytic bile acids.
    Salen G; Tint GS; Shefer S
    Gastroenterol Clin North Am; 1991 Mar; 20(1):171-82. PubMed ID: 2022420
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.